These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16732702)

  • 21. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Europace; 2022 Jul; 24(7):1171-1178. PubMed ID: 35025999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).
    Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W
    Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope.
    Grubb BP; Karas B; Kosinski D; Boehm K
    J Interv Card Electrophysiol; 1999 Jul; 3(2):139-43. PubMed ID: 10387140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What can I do when first-line measures are not enough for vasovagal syncope?
    Hutt Centeno E; Mayuga KA
    Cleve Clin J Med; 2018 Dec; 85(12):920-922. PubMed ID: 30526751
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence-based treatment for vasovagal syncope.
    Kuriachan V; Sheldon RS; Platonov M
    Heart Rhythm; 2008 Nov; 5(11):1609-14. PubMed ID: 18984541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.
    Qingyou Z; Junbao D; Chaoshu T
    J Pediatr; 2006 Dec; 149(6):777-80. PubMed ID: 17137891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management strategies for recurrent vasovagal syncope.
    Vaddadi G; Corcoran SJ; Esler M
    Intern Med J; 2010 Aug; 40(8):554-60. PubMed ID: 20718882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of vasovagal syncope.
    Parry SW; Kenny RA
    QJM; 1999 Dec; 92(12):697-705. PubMed ID: 10581332
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on midodrine in a case of vasodepressor neurogenic syncope.
    Ward C; Kenny RA
    Clin Auton Res; 1995 Oct; 5(5):257-60. PubMed ID: 8563457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharma-clinics. How I treat vasovagal syncope].
    Kulbertus H; Melon P
    Rev Med Liege; 1999 Jun; 54(6):510-3. PubMed ID: 10446518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
    Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
    Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of neurally mediated reflex syncope.
    Guzman JC; Armaganijan LV; Morillo CA
    Cardiol Clin; 2013 Feb; 31(1):123-9. PubMed ID: 23217693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers in syncope: the jury is still out.
    Sheldon RS; Raj SR; Rose S; Connolly SJ
    J Am Coll Cardiol; 2001 Dec; 38(7):2135-6. PubMed ID: 11738330
    [No Abstract]   [Full Text] [Related]  

  • 40. [Successful midodrin treatment for vasovagal syncopes accompanied by asystole].
    Pevzner AV; Kuchinskaia EA; Vershuta EV; Al'bitskaia KV; Kheĭmetz GI; Tripoten' MI; Rogoza AN; Golitsyn SP
    Klin Med (Mosk); 2004; 82(9):53-6. PubMed ID: 15540425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.